INVESTORS
Invest in ValGraph
A Seed Investment (100M KRW) accelerates our enterprise market entry by securing ISO 27001 certifications, regulatory guidance (USP/ISO), and independent GPU infrastructure.
Enterprise Compliance & Roadmap
Achieving complete validation starting with our upcoming MVP launch, followed by 2027 Enterprise On-Premise deployment, and entering Medical Device SW (IEC 62304) by 2028.
Milestone: GxP / CSV Track
With our upcoming MVP Cloud release, we are designed to comply with stringent FDA guidelines for electronic records and signatures (21 CFR Part 11).
Targeting a 2027 Enterprise On-Premise build, we are advancing validation packages in strict accordance with ISPE GAMP 5 Second Edition.
Milestone: Info Security & Expansion
Prioritizing ISMS and ISO 27001 certifications to completely resolve pharmaceutical resistance to cloud adoption.
Thoroughly preparing for comprehensive SOC2 audits in anticipation of our 2028 Medical Device SW (IEC 62304) expansion.
Satisfying the highest domestic and international security regulations to protect our clients' intellectual property within a zero-trust ecosystem.